Oral pharmacokinetic interaction of ester rich fruit juices and pharmaceutical excipients with tenofovir disoproxil fumarate in male Wistar rats

References

• Anderson PL, Kiser JJ, Gardner EM, et al. (2011). Pharmacological considerations for tenofovir and emtricitabine to prevent HIV infection. J Antimicrob Chemother 66:240–50
   PubMed Web of Science ®Google Scholar
• Arimilli MN, Kim CU, Dougherty J, et al. (1997). Synthesis, in vitro biological evaluation and oral bioavailability of 9-[2-(phosphonomethoxy)propyl]adenine (PMPA) prodrugs. Antivir Chem Chemother 8:557–64
   Web of Science ®Google Scholar
• Bailey DG, Malcolm J, Arnold O, et al. (1998). Grapefruit juice-drug interactions. Br J Clin Pharmacol 46:101–10
   PubMed Web of Science ®Google Scholar
• Choi S-U, Bui T, Ho RJY. (2008). pH-dependent interactions of indinavir and lipids in nanoparticles and their ability to entrap a solute. J Pharm Sci 97:931–43
   PubMed Web of Science ®Google Scholar
• Cornaire G, Woodley J, Hermann P, et al. (2004). Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo. Int J Pharm 278:119–31
   PubMed Web of Science ®Google Scholar
• Crauste-Manciet S, Decroix M, Farinotti R, et al. (1997a). Cefpodoxime-proxetil hydrolysis and food effects in the intestinal lumen before absorption: in vitro comparison of rabbit and human material. Int J Pharm 157:153–61
   PubMed Web of Science ®Google Scholar
• Crauste-Manciet S, Huneau JF, Decroix MO, et al. (1997b). Cefpodoxime proxetil esterase activity in rabbit small intestine: a role in the partial cefpodoxime absorption. Int J Pharm 149:241–9
   Web of Science ®Google Scholar
• Foggia M, Nappa S, Bonadies G, et al. (2008). Tenofovir disoproxil fumarate in the clinical practice: an overview. Antiinfect Agents Med Chem 7:285–95
   Google Scholar
• Fukuda K, Guo L, Ohashi N, et al. (2000). Amounts and variation in grapefruit juice of the main components causing grapefruit-drug interaction. J Chromatogr B Biomed Sci Appl 741:195–203
   PubMed Web of Science ®Google Scholar
• Geboers S, Haenen S, Mols R, et al. (2015). Intestinal behavior of the ester prodrug tenofovir DF in humans. Int J Pharm 485:131–7
   PubMed Web of Science ®Google Scholar
• Honda Y, Ushigome F, Koyabu N, et al. (2004). Effects of grapefruit juice and orange juice components on P-glycoprotein- and MRP2-mediated drug efflux. Br J Pharmacol 143:856–64
   PubMed Web of Science ®Google Scholar
• Imai T, Ohura K. (2008). The role of intestinal carboxylesterase in the oral absorption of prodrugs. Curr Drug Metab 11:793–805
   Web of Science ®Google Scholar
• Inoue M, Morikawa M, Tsuboi M, et al. (1979a). Species difference and characterization of intestinal esterase on the hydrolizing activity of ester-type drugs. Jpn J Pharmacol 29:9–16
   PubMedGoogle Scholar
• Inoue M, Morikawa M, Tsuboi M, et al. (1979b). Hydrolysis of ester-type drugs by the purified esterase from human intestinal mucosa. Jpn J Pharmacol 29:17–25
   PubMedGoogle Scholar
• Kane GC, Lipsky JJ. (2000). Drug-grapefruit juice interactions. Mayo Clin Proc 75:933–42
   PubMed Web of Science ®Google Scholar
• Kearney BP, Flaherty JF, Shah J. (2004). Tenofovir disoproxil fumarate: clinical pharmacology and pharmacokinetics. Clin Pharmacokinet 43:595–612
   PubMed Web of Science ®Google Scholar
• Kiser JJ, Carten ML, Aquilante CL, et al. (2008). The effect of lopinavir/ritonavir on the renal clearance of tenofovir in HIV-infected patients. Clin Pharmacol Ther 83:265–72
   PubMed Web of Science ®Google Scholar
• Li M, Si L, Pan H, et al. (2011). Excipients enhance intestinal absorption of ganciclovir by P-gp inhibition: Assessed in vitro by everted gut sac and in situ by improved intestinal perfusion. Int J Pharm 403:37–45
   PubMed Web of Science ®Google Scholar
• Li P, Callery PS, Gan L-S, et al. (2007a). Esterase inhibition by grapefruit juice flavonoids leading to a new drug interaction. Drug Metab Dispos 35:1203–8
   PubMed Web of Science ®Google Scholar
• Li P, Callery PS, Gan LS, et al. (2007b). Esterase inhibition attribute of grapefruit juice leading to a new drug interaction. Drug Metab Dispos 35:1023–31
   PubMed Web of Science ®Google Scholar
• Li P, Zhu C-L, Zhang X-X, et al. (2010). Reversible inhibitory effects of saturated and unsaturated alkyl esters on the carboxylesterases activity in rat intestine. Lipids 45:603–12
   PubMed Web of Science ®Google Scholar
• Lilja JJ, Raaska K, Neuvonen PJ. (2005). Effects of orange juice on the pharmacokinetics of atenolol. Eur J Clin Pharmacol 61:337–40
   PubMed Web of Science ®Google Scholar
• Mallants R, Van Oosterwyck K, Van Vaeck L, et al. (2005). Multidrug resistance-associated protein 2 (MRP2) affects hepatobiliary elimination but not the intestinal disposition of tenofovir disoproxil fumarate and its metabolites. Xenobiotica 35:1055–66
   PubMed Web of Science ®Google Scholar
• Mohri K, Uesawa Y. (2001). Effects of furanocoumarin derivatives in grapefruit juice on nifedipine pharmacokinetics in rats. Pharm Res 18:177–82
   PubMed Web of Science ®Google Scholar
• Murakami E, Wang T, Park Y, et al. (2015). Implications of efficient hepatic delivery by tenofovir alafenamide (GS-7340) for Hepatitis B virus therapy. Antimicrob Agents Chemother 59:3563–9
   PubMed Web of Science ®Google Scholar
• Naesens L, Bischofberger N, Augustijns P, et al. (1998). Antiretroviral efficacy and pharmacokinetics of oral bis(isopropyloxycarbonyloxymethyl)-9-(2-phosphonylmethoxypropyl)adenine in mice. Antimicrob Agents Chemother 42:1568–73
   PubMed Web of Science ®Google Scholar
• Pokharkar VB, Jolly MR, Kumbhar DD. (2015). Engineering of a hybrid polymer-lipid nanocarrier for the nasal delivery of tenofovir disoproxil fumarate: Physicochemical, molecular, microstructural, and stability evaluation. Eur J Pharm Sci 71:99–111
   PubMed Web of Science ®Google Scholar
• Ravi PR, Joseph S, Avula USR, et al. (2015). A simple liquid chromatographic method for the determination of tenofovir in rat plasma and its application to pharmacokinetic studies. Acta Chromatogr 27:597–612
   Web of Science ®Google Scholar
• Ravi PR, Vats R, Thakur R, et al. (2012). Effect of grapefruit juice and ritonavir on pharmacokinetics of lopinavir in Wistar rats. Phytother Res 26:1490–5
   PubMed Web of Science ®Google Scholar
• Shaw J-P, Sueoka CM, Oliyai R, et al. (1997). Metabolism and pharmacokinetics of novel oral prodrugs of 9-[(R)-2-(phosphonomethoxy)propyl]adenine (PMPA) in dogs. Pharm Res 14:1824–9
   PubMed Web of Science ®Google Scholar
• Takanaga H, Ohnishi A, Yamada S, et al. (2000). Polymethoxylated flavones in orange juice are inhibitors of P-glycoprotein but not cytochrome P450 3A4. J Pharmacol Exp Ther 293:230–6
   PubMed Web of Science ®Google Scholar
• Tian R, Koyabu N, Takanaga H, et al. (2002). Effects of grapefruit juice and orange juice on the intestinal efflux of P-glycoprotein substrates. Pharm Res 19:802–9
   PubMed Web of Science ®Google Scholar
• Tong L, Phan TK, Robinson KL, et al. (2007). Effects of human immunodeficiency virus protease inhibitors on the intestinal absorption of tenofovir disoproxil fumarate in vitro. Antimicrob Agents Chemother 51:3498–504
   PubMed Web of Science ®Google Scholar
• Van Gelder J, Annaert P, Naesens L, et al. (1999). Inhibition of intestinal metabolism of the antiviral ester prodrug bis(POC)-PMPA by nature-identical fruit extracts as a strategy to enhance its oral absorption: an in vitro study. Pharm Res 16:1035–40
   PubMed Web of Science ®Google Scholar
• Van Gelder J, Deferme S, Naesens L, et al. (2002). Intestinal absorption enhancement of the ester prodrug tenofovir disoproxil fumarate through modulation of the biochemical barrier by defined ester mixtures. Drug Metab Dispos 30:924–30
   PubMed Web of Science ®Google Scholar
• Van Gelder J, Shafiee M, De Clercq E, et al. (2000). Species-dependent and site-specific intestinal metabolism of ester prodrugs. Int J Pharm 205:93–100
   PubMed Web of Science ®Google Scholar
• Yoshigae Y, Imai T, Horita A, et al. (1998). Species differences in stereoselective hydrolase activity in intestinal mucosa. Pharm Res 15:626–31
   PubMed Web of Science ®Google Scholar
• Yuan LC, Dahl TC, Oliyai R. (2001). Degradation kinetics of oxycarbonyloxymethyl prodrugs of phosphonates in solution. Pharm Res 18:234–7
   PubMed Web of Science ®Google Scholar